Anti UCHL1 pAb (ATL-HPA005993 w/enhanced validation)

Catalog No:
ATL-HPA005993-25
$290.00
Application: WB, ICC, IHC 
Clonality: Polyclonal 
Host: Rabbit 
Reactivity: Human, Mouse, Rat 
Protein Description: ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
Gene Name: UCHL1
Alternative Gene Name: PARK5, PGP9.5, Uch-L1
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000029223: 97%, ENSRNOG00000002343: 97%
Entrez Gene ID: 7345
Uniprot ID: P09936
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Cognate Antibody/Antigen for Anti UCHL1 pAb (ATL-HPA005993 w/enhanced validation)
Antigen PrEST Antigen UCHL1 (ATL-APrEST86224)
Documents & Links for Anti UCHL1 pAb (ATL-HPA005993 w/enhanced validation)
Datasheet Anti UCHL1 pAb (ATL-HPA005993 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti UCHL1 pAb (ATL-HPA005993 w/enhanced validation) at Atlas

Documents & Links for Anti UCHL1 pAb (ATL-HPA005993 w/enhanced validation)
Datasheet Anti UCHL1 pAb (ATL-HPA005993 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti UCHL1 pAb (ATL-HPA005993 w/enhanced validation)

Citations for Anti UCHL1 pAb (ATL-HPA005993 w/enhanced validation) – 21 Found
The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma.
Oncotarget. 2015 Aug 21;6(24):20419-33. doi: 10.18632/oncotarget.3983.  PubMed
UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization.
Sci Rep. 2017 Jul 31;7(1):6879. doi: 10.1038/s41598-017-06605-1.  PubMed
Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human Sertoli Cells.
mBio. 2019 Jul 16;10(4):e01372-19. doi: 10.1128/mBio.01372-19.  PubMed
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.
Cancer Cell. 2020 Jul 13;38(1):60-78.e12. doi: 10.1016/j.ccell.2020.05.001. Epub 2020 May 30.  PubMed
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo.
Cancer Discov. 2021 Jul;11(7):1736-1753. doi: 10.1158/2159-8290.CD-20-1385. Epub 2021 Mar 11.  PubMed
ASCL1 represses a SOX9(+) neural crest stem-like state in small cell lung cancer.
Genes Dev. 2021 Jun;35(11-12):847-869. doi: 10.1101/gad.348295.121. Epub 2021 May 20.  PubMed
Antibody toolkit reveals N-terminally ubiquitinated substrates of UBE2W.
Nat Commun. 2021 Jul 29;12(1):4608. doi: 10.1038/s41467-021-24669-6.  PubMed
A conserved YAP/Notch/REST network controls the neuroendocrine cell fate in the lungs.
Nat Commun. 2022 May 16;13(1):2690. doi: 10.1038/s41467-022-30416-2.  PubMed
Antibody-based proteomics for discovery and exploration of proteins expressed in pancreatic islets.
Discov Med. 2010 Jun;9(49):565-78.  PubMed
UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
Int J Clin Exp Pathol. 2015 Nov 1;8(11):13957-67. eCollection 2015.  PubMed
Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer.
Genes Dev. 2016 Jun 1;30(11):1289-99. doi: 10.1101/gad.279307.116.  PubMed
Xenografting of isolated equine (Equus caballus) testis cells results in de novo morphogenesis of seminiferous tubules but not spermatogenesis.
Andrology. 2017 Mar;5(2):336-346. doi: 10.1111/andr.12308. Epub 2017 Feb 3.  PubMed
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer.
Nature. 2017 May 18;545(7654):360-364. doi: 10.1038/nature22323. Epub 2017 May 10.  PubMed
Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition.
Cancer Discov. 2018 Nov;8(11):1422-1437. doi: 10.1158/2159-8290.CD-18-0385. Epub 2018 Sep 4.  PubMed
Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin.
Cancer Discov. 2018 Oct;8(10):1316-1331. doi: 10.1158/2159-8290.CD-17-0987. Epub 2018 Sep 18.  PubMed
Axon-like protrusions promote small cell lung cancer migration and metastasis.
Elife. 2019 Dec 13;8:e50616. doi: 10.7554/eLife.50616.  PubMed
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.
Cancers (Basel). 2020 Jan 2;12(1):118. doi: 10.3390/cancers12010118.  PubMed
Prognostic potential and oncogenic effects of UCH-L1 expression in hilar cholangiocarcinoma.
Int J Clin Exp Pathol. 2017 Nov 1;10(11):10802-10811. eCollection 2017.  PubMed
Small-Molecule Activity-Based Probe for Monitoring Ubiquitin C-Terminal Hydrolase L1 (UCHL1) Activity in Live Cells and Zebrafish Embryos.
J Am Chem Soc. 2020 Sep 30;142(39):16825-16841. doi: 10.1021/jacs.0c07726. Epub 2020 Sep 18.  PubMed
Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities.
Cancer Res. 2022 Apr 15;82(8):1589-1602. doi: 10.1158/0008-5472.CAN-22-0059.  PubMed
A multiplexed in vivo approach to identify driver genes in small cell lung cancer.
Cell Rep. 2023 Jan 31;42(1):111990. doi: 10.1016/j.celrep.2023.111990. Epub 2023 Jan 13.  PubMed